Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2010
08/05/2010US20100197608 Use of melanotrophin-potentiating factor as a therapeutic agent
08/05/2010US20100197604 Use of peptide as a therapeutic agent
08/05/2010US20100197601 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection
08/05/2010US20100197600 Use of the peptide his-ser-leu-gly-lys-trp-leu-gly-his-pro-asp-lys-phe alone or in combination with the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys-oh as a therapeutic agent
08/05/2010US20100197599 Use of a peptide as a therapeutic agent
08/05/2010US20100197588 Use of a peptide as a therapeutic agent
08/05/2010US20100197587 Use of a peptide as a therapeutic agent
08/05/2010US20100197585 Use of a rgd-peptide and/or parathyroid hormone (1-34) as anti-hiv agent
08/05/2010US20100197576 Polypeptides or fusion proteins thereof inhibiting transmigration of leucocytes or growth and/or metastasis of cancer cells
08/05/2010US20100197575 Soluble interleukin-20 receptor
08/05/2010US20100197572 Use of somatostatin-14 as a therapeutic agent
08/05/2010US20100196488 Pharmaceutical Formulation
08/05/2010US20100196481 Spinal cord injury, inflammation, and immune-disease: local controlled release of therapeutic agents
08/05/2010US20100196476 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof
08/05/2010US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
08/05/2010US20100196451 Vaccines Containing Non-Live Antigenic Vectors
08/05/2010US20100196421 clostridial neurotoxin propeptide which has a light chain region, a heavy chain region, where the light and heavy chain regions are linked by a disulfide bond, and an intermediate region connecting the light and heavy chain regions; intermediate region has a highly specific protease cleavage site
08/05/2010US20100196418 UNIVERSAL CARRIER FOR TARGETING MOLECULES TO Gb3 RECEPTOR EXPRESSING CELLS
08/05/2010US20100196417 Compositions comprising a b subunit of shiga toxin and a means stimulating nkt cells
08/05/2010US20100196409 Basb006 polypeptides from neisseria meningitidis and immunogenic compositions thereof
08/05/2010US20100196407 Tick galectin
08/05/2010US20100196406 Agents for the treatment of inflammatory diseases and methods of using same
08/05/2010US20100196402 Method for Predicting the Response of a Patient to Treatment with an Anti-TNF Alpha Antibody
08/05/2010US20100196401 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products
08/05/2010US20100196397 Five-helix protein
08/05/2010US20100196386 Ligands of hvem for treating hematologic malignancies and autoimmune diseases
08/05/2010US20100196384 Anti-histone h1 monoclonal antibody and hybridoma for the production thereof
08/05/2010US20100196374 Methods and compositions for treating autoimmune disease
08/05/2010US20100196372 FcgammaRIIB Fusion Proteins and Compositions Thereof
08/05/2010US20100196339 Microparticle-Based Transfection and Activation of Dendritic Cells
08/05/2010US20100196336 Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
08/05/2010US20100196318 Methods of Treating Inflammatory and Autoimmune Diseases with Natalizumab
08/05/2010US20100196312 Glycosylated il-7, preparation and uses
08/05/2010US20100196309 Interleukin-21 variants with altered binding to the il-21 receptor
08/05/2010US20100196267 Humanized L243 Antibodies
08/05/2010CA2787697A1 Compositions comprising chlamydia antigens
08/05/2010CA2750988A1 Tslp promotes immune evasion and persistence of viruses
08/05/2010CA2750922A1 Li-key hybrid peptides that modulate the immune response to influenza
08/05/2010CA2750188A1 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
08/05/2010CA2750086A1 Scriptaid isosteres and their use in therapy
08/04/2010EP2213743A1 Albumin fusion proteins
08/04/2010EP2213737A1 Double-stranded oligonucleotides
08/04/2010EP2213682A1 TSLP promotes immune evasion and persistence of viruses
08/04/2010EP2213302A2 DR4 antibodies and uses thereof
08/04/2010EP2213301A1 Immune response inducer
08/04/2010EP2213292A1 Double-stranded oligonucleotides
08/04/2010EP2211892A2 Composition
08/04/2010EP2211868A2 Silicate containing compositions and methods of treatment
08/04/2010EP2211841A1 A method of prophylaxis and agents for use therein
08/04/2010EP1920778B1 Composition for treatment of uveitis
08/04/2010EP1635863B1 Compositions to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes
08/04/2010EP1429750B1 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
08/04/2010EP1343769B1 Benzoylpyridazines
08/04/2010CN201537287U Thymosin alpha 1 preparation
08/04/2010CN101796187A Double-stranded RNA originating in lactic acid bacterium
08/04/2010CN101796074A Anti-notch1 NRR antibodies and methods using same
08/04/2010CN101796073A Humanized antibodies against CXCR3
08/04/2010CN101796069A Vm23 and Vm24, two scorpion peptides that block human T-lymphocyte potassium channels (sub-type Kv1.3) with high selectivity and decrease the in vivo DTH-responses in rats
08/04/2010CN101795579A Protein free formula
08/04/2010CN101792493A Method for preparing spreading hedyotis herb polysaccharide
08/04/2010CN101792489A Preparation and application of human galectin-9 deletant for enhancement of immune response
08/04/2010CN101791399A Water-containing liquid allergic reaction bacterin preparation for mouth mucosa drug administration
08/04/2010CN101791383A Compound chicory series product and effect of adjusting blood sugar, blood fat and blood uric acid
08/04/2010CN101791379A Traditional Chinese medicine compound oral preparation for preventing and treating tumor diseases
08/04/2010CN101791355A Medicine composition used for preventing birth defects, improving memory and regulating immunity
08/04/2010CN101791332A Compound gingko health product solid preparation
08/04/2010CN101791315A Compound monoammonium glycyrrhizinate S pharmaceutical composition and method for preparing high-capacity injection
08/04/2010CN101791301A Application of diallyl disulphide in preparing broad-spectrum antiviral medicament
08/04/2010CN101791295A Compound monoammonium glycyrrhizinate S pharmaceutical composition and method for preparing frozen powder injection
08/04/2010CN101015551B Preparing method of triptolide stereoscopic stable liposome nano granule
08/03/2010US7767790 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders
08/03/2010US7767685 8-pyrazolo-xanthine derivatives such as 2-[3-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-5-methyl-pyrazol-1-yl]-N-phenyl-acetamide, used for treating asthma, rhinitis, dermatitis, diabetes, tumors, reperfusion injuries, inflammatory bowel disease, autoimmune diseases and vison defects
08/03/2010US7767456 Non-viral gene delivery system
08/03/2010US7767223 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use
08/03/2010US7767209 Modified vaccinia virus Ankara (MVA) mutant and use thereof
08/03/2010US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
08/03/2010US7767198 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant; high dispersibilities
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
08/03/2010CA2441792C Carboline derivatives as inhibitors of phosphodiesterase 5 (pdes) for the treatment of cardiovascular diseases and erectile dysfunction
08/03/2010CA2409828C Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base
08/03/2010CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors
08/03/2010CA2401342C Human antibodies against eotaxin and their use
08/03/2010CA2381047C Vaccine against hepatitis b virus and human papilloma virus
08/03/2010CA2359776C Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies
08/03/2010CA2263106C Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin
08/03/2010CA2230748C Rapamycin formulations for oral administration
07/2010
07/29/2010WO2010085697A1 Improved vaccines for human papilloma virus and methods for using the same
07/29/2010WO2010085584A1 Pyrazole-i, 2, 4 -oxad iazole derivatives as s.phing0sine-1-ph0sphate agonists
07/29/2010WO2010085582A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
07/29/2010WO2010085581A1 Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
07/29/2010WO2010085377A2 Hydroxamic acid derivatives
07/29/2010WO2010084999A1 Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases
07/29/2010WO2010084851A1 Peptide capable of binding to immunoglobulin
07/29/2010WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
07/29/2010WO2010084356A1 Treatment of neurotrophic factor mediated disorders
07/29/2010WO2010084158A1 Anti-cd 160 monoclonal antibodies and uses thereof
07/29/2010WO2010083730A1 New uses of tooth related stem cells
07/29/2010WO2010083728A1 Nanoparticle formulated glycolipid antigens for immunotherapy
07/29/2010WO2010083649A1 Bisarylurea derivatives and their use
07/29/2010WO2010064958A3 Protein kinase c inhibitors exhibiting an anti-inflammatory, anti-allergic and anti-asthma effect
1 ... 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 ... 1172